Angiex, Inc. · CIK 1710380
Angiex, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
2
Original notices
1
Amendments
1
Activity
Aug 14, 2025
through Sep 26, 2025
through Sep 26, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Aug 14, 2025 · D | Sep 26, 2025 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $20,284,497 | $28,409,510 | $8,125,013 |
| Reported amount sold | $10,980,030 | $21,991,695 | $11,011,665 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001710380-25-000003 · Later SEC source: 0001710380-25-000005
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $28,409,510
- Reported exemptions
- Rule 506(c)
- Reported amount sold
- $21,991,695
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Form D filings (2)
-
0001710380-25-000005D/A · Sep 26, 2025 · BiotechnologyOffering: $28,409,510Sold: $21,991,695
Compared with 0001710380-25-000003:
- Reported offering amount: $20,284,497 → $28,409,510
- Reported amount sold: $10,980,030 → $21,991,695
-
0001710380-25-000003D · Aug 14, 2025 · BiotechnologyOffering: $20,284,497Sold: $10,980,030